Article Versions Notes

Liang K-H, Chen S-F, Lin Y-H, Chu Y-D, Lin Y-H, Lai M-W, Lin C-L, Yeh C-T. Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular Carcinoma. Biomedicines. 2021; 9(11):1539. https://doi.org/10.3390/biomedicines9111539

Liang, Kung-Hao, Sung-Fang Chen, Yu-Hua Lin, Yu-De Chu, Yang-Hsiang Lin, Ming-Wei Lai, Chih-Lang Lin, and Chau-Ting Yeh. 2021. "Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular Carcinoma" Biomedicines 9, no. 11: 1539. https://doi.org/10.3390/biomedicines9111539

Liang, K.-H., Chen, S.-F., Lin, Y.-H., Chu, Y.-D., Lin, Y.-H., Lai, M.-W., Lin, C.-L., & Yeh, C.-T. (2021). Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular Carcinoma. Biomedicines, 9(11), 1539. https://doi.org/10.3390/biomedicines9111539